Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mecklenburg centre to improve breast cancer care:

This article was originally published in Clinica

Executive Summary

Hospitals and doctors in the German federal state of Mecklenburg-Vorpommern have established a telemedicine network with the aim of improving breast cancer care. "We know that in the areas of prevention, diagnostics, therapy and post procedural care Germany does not comprehensively match international standards," said experts from the Vorpommern tumour centre at the University of Greifswald. Effective breast cancer care will now be channelled through a new cross-disciplinary centre, which has passed the certification programme for quality assurance set up according to guidelines laid down by the German cancer society and the German senology society. The telemedicine network will be divided into telepathology, teleradiology and teleconference sections and will be operational by the end of 2003.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT064054

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel